FDA Approves Label Changes for Zolpidem Products
The US Food and Drug Administration (FDA) is notifying the public that FDA has approved label changes specifying new dosing recommendations for zolpidem products (Ambien, Ambien CR, and Edluar), which are widely prescribed sleep medications.
Extra Focus Needed with Insomnia Rx
A common insomnia medication can be dangerous unless taken with care. Bad reactions between medications or not following instructions and warning labels can send users to the emergency room.